Timothy J Wierzbicki MD

Clinical Trials

• Auditory Function in Patients With and Without Multiple Sclerosis Start of enrollment: 2001 Oct 01

  Completed

  Phase 2

• Long Term Study of Avonex Therapy Following a First Attack of Multiple Sclerosis Start of enrollment: 2001 Feb 01

  Completed

  Phase 4

• Infections and Autoimmunity: Autobodies Screening in Multiple Sclerosis Start of enrollment: 2005 Sep 01

  Unknown status

  Phase 1

• Safety and Efficacy of Buprenorphine Transdermal System (BTDS) in Subjects With Moderate to Severe Low Back Pain Start of enrollment: 2004 Feb 01

  Terminated

  Phase 3

• Success of Titration, Analgesics, and B.E.T.A Nurse Support on Acceptance Rates in Early Multiple Sclerosis (MS) Treatment With Betaseron Start of enrollment: 2007 May 01

  Completed

• Safety/Efficacy of Tigan® to Control Nausea/Vomiting Experienced During Apokyn® Initiation and Treatment Start of enrollment: 2007 May 01

  Completed

  Phase 4

• Evaluate Early Glatiramer Acetate Treatment in Delaying Conversion to Clinically Definite Multiple Sclerosis of Subjects Presenting With Clinically Isolated Syndrome Start of enrollment: 2004 Jan 01

  Completed

  Phase 3

• Gene Expression Profiles in Multiple Sclerosis (MS) Start of enrollment: 2006 Mar 01

  Completed

• NINDS CRC Chronic Migraine Treatment Trial Start of enrollment: 2008 Oct 01

  Completed

  Phase 3

• Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs Start of enrollment: 2009 Apr 01

  Completed

  Phase 3

• Eslicarbazepine Acetate Monotherapy Long Term Study Start of enrollment: 2009 Aug 01

  Completed

  Phase 3

• Safety and Immunologic Effect of Low Dose Versus High Dose Vitamin D3 in Multiple Sclerosis Start of enrollment: 2010 Mar 01

  Completed

  Phase 1

• Natalizumab Treatment of Progressive Multiple Sclerosis Start of enrollment: 2010 Mar 01

  Completed

  Phase 2

• Improving Hand Use in Multiple Sclerosis Start of enrollment: 2010 Feb 01

  Unknown status

  Phase 2

• Effect of Aerobic Exercise on Side Effects of Disease Modifying Therapy With Subcutaneous Interferon-b1b in Patients With Multiple Sclerosis Start of enrollment: 2010 May 01

  Completed

  Not Applicable

• Safety of BTDS in Subjects With Low Back Pain: A 52-Week Extension Phase of BUP3015 Start of enrollment: 2004 Jun 01

  Terminated

  Phase 3

• Safety of Buprenorphine Transdermal Patch (BTDS) in Osteoarthritis Pain: a 52-Week Extension Phase Start of enrollment: 2004 Apr 01

  Terminated

  Phase 3

• An Observational Study Comparing Multiple Sclerosis International Quality of Life Questionnaire (MusiQoL) and Multiple Sclerosis Quality of Life-54 Instrument (MSQOL-54) in Relapsing Multiple Sclerosis (RMS) Patients on Long-term Rebif® Therapy Start of enrollment: 2005 Sep 01

  Completed

• A Two Part Study (306A/306B) to Assess Droxidopa in Treatment of NOH in Patients With Parkinson's Disease Start of enrollment: 2010 Jun 01

  Completed

  Phase 3

• A 6-month, Randomized, Open-label, Patient OutComes, Safety and Tolerability Study of Fingolimod (FTY720) 0.5 mg/Day vs. Comparator in Patients With Relapsing Forms of Multiple Sclerosis Start of enrollment: 2010 Aug 01

  Completed

  Phase 4

• Safety and Efficacy of AVP-923 in the Treatment of Central Neuropathic Pain in Multiple Sclerosis Start of enrollment: 2011 Sep 08

  Completed

  Phase 2

• Supported Treadmill Training for Progressive Multiple Sclerosis Start of enrollment: 2008 Apr 01

  Completed

  Not Applicable

• Efficacy and Safety of Oxycodone/Naloxone Controlled-release Tablets (OXN) Compared to Placebo in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain Start of enrollment: 2011 May 01

  Completed

  Phase 3

• Head Circumference Growth in Children Who Develop Multiple Sclerosis Later in Life Start of enrollment: 2011 Jun 01

  Withdrawn

• Responsiveness to Dalfampridine-ER Treatment Among Multiple Sclerosis Patients Start of enrollment: 2010 Aug 01

  Completed

• Oral Prednisone Taper Versus Placebo for the Treatment of Acute Relapses in Multiple Sclerosis Start of enrollment: 2011 Aug 01

  Terminated

  Phase 4

• Efficacy and Safety of Masitinib in the Treatment of Progressive Multiple Sclerosis Start of enrollment: 2011 Aug 01

  Completed

  Phase 3

• Safety Study in Patients With Multiple Sclerosis Treated Fingolimod or Other Approved Disease-modifying Therapies Start of enrollment: 2011 Aug 01

  Completed

• Efficacy and Safety of Hydrocodone Bitartrate (HYD) in Subjects With Moderate to Severe Chronic Low Back Pain Start of enrollment: 2011 Oct 01

  Completed

  Phase 3

• Estriol Treatment in Multiple Sclerosis (MS): Effect on Cognition Start of enrollment: 2011 Oct 01

  Recruiting

  Phase 2

• Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS) Start of enrollment: 2011 Nov 01

  Completed

  Phase 2

• A Research Study of an Investigational Drug ALO-02 (Oxycodone Hydrochloride and Naltrexone Hydrochloride) in Patients With Moderate to Severe Chronic Low Back Pain Start of enrollment: 2012 Jun 01

  Completed

  Phase 3

• Analyze the Myelin-TRAP as Diagnostic Tool in Multiple Sclerosis Start of enrollment: 2012 Apr 01

  Terminated

  Not Applicable

• A Pilot Study to Assess microRNA Biomarkers in Early and Later Stage Multiple Sclerosis Start of enrollment: 2012 Nov 01

  Completed

• Efficacy Study of Arbaclofen to Treat Spasticity in Multiple Sclerosis Start of enrollment: 2012 Nov 01

  Completed

  Phase 3

• Join now to see all